Session

Back to Programme Overview

Intravesical GAG therapy: Application and impact on patient and public health

Industry session by IBSA

  • Location:
    Room Amsterdam, North Hall (Level 1)
  • Chairs:
     S. Droupy, Nîmes (FR)
     J.C. Goddard, Leicester (GB)
  • Aims and objectives of this session

    Clinical Practice Guidelines represent an important tool for making clinical decisions based on evidence. When enough research data are available, the guidelines should promptly incorporate and disseminate these updated evidences for the awareness of the health and social care professionals, to support their decision for the best care of the patient.
    The faculty of experts involved in this symposium will review the available and latest clinical evidences on intravesical instillations with glycosaminoglycans (GAGs) in patients with different forms of cystitis and will discuss their inclusion in the Clinical Practice Guidelines, as a recommended therapeutic option.

Cystitis and pelvic pain management: Guidelines versus real world practice
 J.C. Goddard, Leicester (GB)
Bladder pain: The patient perspective
 J.M. Meijlink, Naarden (NL)
The therapeutic approach to different forms of cystitis: Their impact on public health
 S. Droupy, Nîmes (FR)
Is the clinical practice aligned with the latest scientific evidences on GAG therapy?
 D.A.W. Janssen, Nijmegen (NL)
Discussion and final remarks